Biosplice Therapeutics - Crunchbase Company Profile & Funding
Progressive Diagnostics Crunchbase Company Profile & Funding
Biosplice Therapeutics - Crunchbase Company Profile & Funding. Ics is an ict company that provides software and system products. Companies like biosplice therapeutics include twist.
Progressive Diagnostics Crunchbase Company Profile & Funding
Biosplice therapeutics is an american pharmaceutical company engaged in the development of alternative splicing technologies. Explore biosplice therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here! 11 rows biosplice therapeutics has raised a total of $799m in funding over 6 rounds. Ics is an ibm and salesforce software developer and consulting company. Biosplice therapeutics has produced fresh biological insights and unique chemical equity that delivers therapeutic modulation of alternative splicing by targeting the clk/dyrk family kinases. List of biosplice therapeutics 's 6 funding rounds from 12 investors. Ics is an ict company that provides software and system products. Summary financials people technology signals & news similar companies. The company asserts that medicines that can harness this process will help cure musculoskeletal, ummune and oncological disorders. Summary people technology signals & news similar companies.
This profile is based on publicly available information. Explore biosplice therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here! Ics is an ibm and salesforce software developer and consulting company. Its mission is to improve clinical outcomes and the quality of life for all. Ics is an ict company that provides software and system products. Summary people technology signals & news similar companies. Stemming from foundational discoveries in wnt pathway modulation, biosplice has elucidated novel biology linking clk/dyrk kinases to the therapeutic regulation of alternative splicing. Funding stage early stage venture. Onal discoveries in wnt pathway modulation, biosplice has elucidated novel biology linking clk/dyrk kinases to the therapeutic regulation of alternative splicing. Summary people technology signals & news similar companies. The company asserts that medicines that can harness this process will help cure musculoskeletal, ummune and oncological disorders.
